drugset / Trial / NCT00680160
Absorption and Systemic Study of AN2690 in Patients With Moderate to Severe Onychomycosis (ADME I)
Open-labelTreatment
Summary
The purpose of the study is to determine the absorption, systemic pharmacokinetics and accumulation in the nail of AN2690 during a 28 day period of daily application of a 7.5% solution of AN2690 to all 10 toenails of up to 25 otherwise healthy adult patients with onychomycosis.
Timeline
- Start
- 2006-04-30
- Primary completion
- 2007-05-09
- Completion
- 2007-05-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tavaborole | Small molecule | 7.5 % | Topical |